Vertaling van "al cost-effective treatment " (Nederlands → Frans) :

Lederle F, Busch D, Mattox K et al. Cost-effective treatment in the elderly. A randomized double-blind comparison of sorbitol and lactulose.
A randomized double-blind comparison of sorbitol and lactulose.

patients remain on one type of treatment throughout their smoking cessation therapy costs and consequences of side-effects of bupropion or NRT were not taken into account
patients remain on one type of treatment throughout their smoking cessation therapy costs and consequences of side-effects of Buproprion or NRT were not taken into account

Odds ratio of NRT versus control: 1.67 Odds ratio of bupropion versus control: 2.1 Odds ratio of NRT+bupropion versus control: 2.65 From these Odds Ratios and information on the control 12-month quit rate in the comparator intervention (0.04 for brief advice and 0.10 for counselling), the 12-month quit rate of treatment is calculated: treated quit rate for brief advice+NRT: 0.0650 treated quit rate for brief advice+bupropion: 0.0805 treated quit rate for brief advice+bupropion+NRT: 0.0994 treated quit rate for counselling+NRT: 0.1565 treated quit rate for counselling+bupropion: 0.1892 treated quit rate for counselling+bupropion+NRT: 0.2275 spontaneous cessation rate: 0.01. lifetime relapse rate: 40% (range 30-50%). number of LYG per quitter: 2 (range 1-3). number of QALYs gained per quitter: 2.7 (range 1.35-4.05) not reported The table gives an overview of the assumptions with respect to costs and effects (quit rates) in the average scenario.
Odds ratio of NRT versus control: 1.67 Odds ratio of Buproprion versus control: 2.1 Odds ratio of NRT+Buproprion versus control: 2.65 From these Odds Ratios and information on the control 12-month quit rate in the comparator intervention (0.04 for brief advice and 0.10 for counselling), the 12-month quit rate of treatment is calculated: treated quit rate for brief advice+NRT: 0.0650 treated quit rate for brief advice+Buproprion: 0.0805 treated quit rate for brief advice+Buproprion+NRT: 0.0994 treated quit rate for counselling+NRT: 0.1565 treated quit rate for counselling+Buproprion: 0.1892 treated quit rate for counselling+Buproprion+NRT: 0.2275 spontaneous cessation rate: 0.01. lifetime relapse rate: 40% (range 30-50%). number of LYG per quitter: 2 (range 1-3). number of QALYs gained per quitter: 2.7 (range 1.35-4.05) not reported The table gives an overview of the assumptions with respect to costs and effects (quit rates) in the average scenario.

36. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
36. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ et al. The clinical effectiveness and cost-effectiveness of Bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.

(Jensen 2011) Jensen JT, Parke S, Mellinger U et al. Effective treatment of heavy menstrual bleeding with estradiol vaerate and diénogest.
(Jensen 2011) Jensen JT, Parke S, Mellinger U et al. Effective treatment of heavy menstrual bleeding with estradiol vaerate and

DOI: 10.1002/14651858.CD003244.pub2. de Wit NJ, de Boer W, Geldhof H et al. Treatment of gastro-oesophagal reflux disease with rabeprazole in primary and secondary care does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD003244.

L, et al. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
L, et al. Single-center trials show larger treatment effects than multicenter trials: evidence from a metaepidemiologic study.

Boussageon R, Bejan-Angoulvant T, Saadatian M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.
DOI : 10.1002/ 14651858.CD008143.pub2. Boussageon R, Bejan-Angoulvant T, Saadatian M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

effective for the treatment of death rattle in terminal care.
for the treatment of death rattle in terminal care.

40.Raistrick D, Heather N, Godfrey C. Review of the effectiveness of treatment for alcohol problems.
40. Raistrick D, Heather N, Godfrey C. Review of the effectiveness of treatment for alcohol problems.